Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53

United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$2.52M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$312.40M

$707.11K on a plan · $98.75M straight out of an exercise

Sold at will

$212.94M

115 of 287 sales

Net

−$309.88M

−$210.42M against sales at will